Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$18.95
-0.50-2.57%
Denali Therapeutics Inc (DNLI) Stock Price, Quote, News & History
DNLINASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegenerative diseases. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Denali Therapeutics (NASDAQ:DNLI) through any online brokerage.
Other companies in Denali Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Denali Therapeutics has a consensus price target of $35.16.
The stock price for Denali Therapeutics (NASDAQ: DNLI) is $18.95 last updated .
There are no upcoming dividends for Denali Therapeutics.
Denali Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Denali Therapeutics.
Denali Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
